Metoprolol Succinate Tablet, Extended Release
Product Images NDC 60760-993

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 60760-993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of metoprolol succinate shown as two molecular components with labeled functional groups, including hydroxyl, amine, and carboxyl groups, representing the active ingredient in metoprolol succinate extended-release tablets.*

FDA Label Image

Picture-1 (Picture 1)

A forest plot titled "Results for Subgroups in MERIT-HF" displaying relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure (time to first event) across various subgroups such as geographical location, NYHA class, ejection fraction, etiology, sex, race, myocardial infarction history, diabetes, hypertension, and heart rate. The plot compares outcomes favoring metoprolol succinate extended release tablets versus placebo.*

FDA Label Image

60760-634 (Metoprolol Succinate Er 50mg 90ct 60760 634 90)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.